Texting teens: a new way to ease the diabetes transition?

NCT ID NCT05434754

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether personalized text messages could help young adults with type 1 diabetes feel more confident managing their condition as they moved from pediatric to adult care. 234 participants received either usual care or usual care plus a text messaging program. The goal was to see if the texts improved their self-efficacy—how sure they felt about managing their diabetes—after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
text messaging algorithm
What this could lead to
If successful, this could offer a simple, low-cost way to support young adults with type 1 diabetes during the stressful switch to adult care.
What could go wrong
This is a completed trial, but the intervention is just text messages—it may not improve diabetes management or health outcomes significantly. Results are based on self-reported confidence, not clinical measures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Eastern Ontario

    Ottawa, Ontario, K1H8L1, Canada

  • McGill University Health Center

    Montreal, Quebec, H3G1A4, Canada

  • Oak Valley Health

    Markham, Ontario, L9P1S4, Canada

  • Saint Justine Hospital

    Montreal, Quebec, H3T1C5, Canada

  • The Hospital for Sick Children

    Toronto, Ontario, M5G1X8, Canada

  • Trillium Health Partners

    Mississauga, Ontario, L5B2V2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.